General Information of the Compound
Compound ID |
CP0245025
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
2-Phenyl-3-piperidin-4-yl-1H-indole
Show/Hide
|
||||||||||||||||||
Synonyms |
1H-Indole,2-phenyl-3-(4-piperidinyl)-
2-PHENYL-3-(PIPERIDIN-4-YL)-1H-INDOLE
2-Phenyl-3-(4-piperidinyl)-1H-indole
2-Phenyl-3-piperidin-4-yl-1H-indole
221109-26-8
3-(Piperidin-4-yl)-2-phenyl-1H-indole
AJ-42917
AKOS015898489
AM20030371
ANW-46494
AX8078102
BDBM50095050
CHEMBL295559
CP-220
CTK4E8621
DTXSID60432328
FT-0707553
FWPAVENSJPMGJO-UHFFFAOYSA-N
KB-231980
P13451
SCHEMBL7962369
ST2404535
TC-135239
W4568
ZINC2580888
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C19H20N2
|
||||||||||||||||||
Molecular Weight |
276.383
|
||||||||||||||||||
Canonical SMILES |
C1CC(CCN1)c1c([nH]c2ccccc12)-c1ccccc1
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C19H20N2/c1-2-6-15(7-3-1)19-18(14-10-12-20-13-11-14)16-8-4-5-9-17(16)21-19/h1-9,14,20-21H,10-13H2
Show/Hide
|
||||||||||||||||||
InChIKey |
FWPAVENSJPMGJO-UHFFFAOYSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00825, 5-hydroxytryptamine receptor 2A
Protein ID: PT00939, 5-hydroxytryptamine receptor 2C
Protein ID: PT01005, D(2) dopamine receptor
Protein ID: PT00897, Potassium voltage-gated channel subfamily H member 2
Clinical Information about the Compound